IRIS
KLAIN, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.522
NA - Nord America 4.530
EU - Europa 3.826
SA - Sud America 677
AF - Africa 140
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 14.705
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.322
SG - Singapore 2.540
RU - Federazione Russa 1.743
CN - Cina 1.083
VN - Vietnam 880
IT - Italia 722
BR - Brasile 538
HK - Hong Kong 455
DE - Germania 242
FR - Francia 209
UA - Ucraina 173
FI - Finlandia 157
GB - Regno Unito 131
NL - Olanda 126
IN - India 125
CA - Canada 121
IE - Irlanda 112
BD - Bangladesh 69
AR - Argentina 55
JP - Giappone 54
MX - Messico 51
CI - Costa d'Avorio 47
SE - Svezia 47
KR - Corea 46
ZA - Sudafrica 37
IQ - Iraq 35
PH - Filippine 35
PL - Polonia 32
AT - Austria 27
ID - Indonesia 26
ES - Italia 22
TR - Turchia 22
TH - Thailandia 20
EC - Ecuador 19
UZ - Uzbekistan 18
BE - Belgio 15
PK - Pakistan 14
BG - Bulgaria 13
TW - Taiwan 13
CO - Colombia 12
CL - Cile 11
IL - Israele 11
PY - Paraguay 11
AE - Emirati Arabi Uniti 10
VE - Venezuela 10
IR - Iran 9
MA - Marocco 9
MY - Malesia 9
PE - Perù 9
EG - Egitto 8
CH - Svizzera 7
KE - Kenya 7
SA - Arabia Saudita 7
TN - Tunisia 7
AL - Albania 6
JO - Giordania 6
TT - Trinidad e Tobago 6
NP - Nepal 5
RO - Romania 5
SI - Slovenia 5
UY - Uruguay 5
BB - Barbados 4
BY - Bielorussia 4
CZ - Repubblica Ceca 4
EU - Europa 4
GY - Guiana 4
LT - Lituania 4
PA - Panama 4
PT - Portogallo 4
AM - Armenia 3
AO - Angola 3
AZ - Azerbaigian 3
BO - Bolivia 3
CR - Costa Rica 3
DK - Danimarca 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
PR - Porto Rico 3
SK - Slovacchia (Repubblica Slovacca) 3
BH - Bahrain 2
DJ - Gibuti 2
DM - Dominica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GA - Gabon 2
GR - Grecia 2
GT - Guatemala 2
HR - Croazia 2
HT - Haiti 2
JM - Giamaica 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
MK - Macedonia 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
OM - Oman 2
RW - Ruanda 2
SN - Senegal 2
TZ - Tanzania 2
Totale 14.675
Salva come PNG Salva come JPEG
Città #
Singapore 1.166
San Jose 697
Hong Kong 435
Moscow 425
Ashburn 415
Beijing 301
Chandler 254
Santa Clara 238
Ho Chi Minh City 237
Hanoi 191
Hefei 184
Naples 170
The Dalles 147
Millbury 145
Lauterbourg 142
Los Angeles 125
Amsterdam 111
Jacksonville 111
Princeton 104
Boston 90
Nanjing 79
Council Bluffs 72
Buffalo 69
Napoli 66
New York 57
Redondo Beach 53
São Paulo 53
Munich 52
Ottawa 50
Woodbridge 49
Wilmington 47
Dallas 45
Haiphong 44
Tokyo 42
Houston 41
Da Nang 36
Des Moines 36
Kochi 35
Lawrence 35
Orem 35
Seoul 33
Frankfurt am Main 32
London 32
Toronto 27
Nuremberg 26
Seattle 26
Dublin 25
Helsinki 25
Nanchang 25
Brooklyn 24
Warsaw 23
Milan 21
Rio de Janeiro 21
Washington 21
Dong Ket 20
Hebei 20
Rome 20
Tianjin 20
Mexico City 19
San Giovanni Rotondo 19
Chennai 18
Denver 18
Jiaxing 18
Johannesburg 18
Montreal 18
Lappeenranta 17
Chicago 16
Stockholm 16
Turku 16
Hải Dương 15
Atlanta 14
Baghdad 14
Biên Hòa 14
Falls Church 14
Norwalk 14
Tashkent 14
San Francisco 13
Changsha 12
Shenyang 12
Sofia 12
Vienna 12
Curitiba 11
Dhaka 11
Ninh Bình 11
Manchester 10
Brasília 9
Mumbai 9
Phoenix 9
Poplar 9
Porto Alegre 9
San Mateo 9
Courcelles 8
Falkenstein 8
Guangzhou 8
Hangzhou 8
Kunming 8
New Delhi 8
Salerno 8
Thái Bình 8
Belo Horizonte 7
Totale 7.646
Salva come PNG Salva come JPEG
Nome #
Type 2 Deiodinase Thr92Ala Polymorphism and Aging Are Associated with a Decreased Pituitary Sensitivity to Thyroid Hormone 171
Added prognostic value of left ventricular shape by gated SPECT imaging in patients with suspected coronary artery disease and normal myocardial perfusion 159
Combined evaluation of regional coronary artery calcium and myocardial perfusion by 82Rb PET/CT in the identification of obstructive coronary artery disease 155
Combination of Lenvatinib and Pembrolizumab as Salvage Treatment for Paucicellular Variant of Anaplastic Thyroid Cancer: A Case Report 155
Comparison between computed tomography multislice and high-field magnetic resonance in the diagnostic evaluation of patients with renal masses 152
Management of differentiated thyroid cancer through nuclear medicine facilities during Covid-19 emergency: the telemedicine challenge 151
Long-term management of lenvatinib-treated thyroid cancer patients: a real-life experience at a single institution 151
Assessment of acute myocarditis by cardiac magnetic resonance imaging: Comparison of qualitative and quantitative analysis methods 150
Quantification of Coronary Artery Atherosclerotic Burden and Muscle Mass: Exploratory Comparison of Two Freely Available Software Programs 150
Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males 149
Prediction of 2-[18F]FDG PET-CT SUVmax for Adrenal Mass Characterization: A CT Radiomics Feasibility Study 146
Prognostic Value of Hybrid PET/MR Imaging in Patients with Differentiated Thyroid Cancer 144
Diagnosis, Management and Theragnostic Approach of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms 141
La scintigrafia con 131I metaiodobenzilguanidina in pazienti con sospetto feocromocitoma: confronto con TC e parametri bioumorali 141
First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings 139
Tumor Burden of Iodine-Avid Bone Metastatic Thyroid Cancer Identified via 18F-Sodium Fluoride PET/CT Imaging 138
Imaging medullary thyroid cancer patients with detectable serum markers: state of the art and future perspectives 138
The role of dynamic post-contrast T1-w MRI sequence to characterize lipid-rich and lipid-poor adrenal adenomas in comparison to non-adenoma lesions: preliminary results 136
Risk of structural persistent disease in pediatric patients with low or intermediate risk differentiated thyroid cancer 136
Minimally invasive percutaneous treatment for osteoid osteoma of the Spine. A case report 136
Whole-body radioiodine effective half-life in patients with differentiated thyroid cancer 136
Ablation rate after radioactive iodine therapy in patients with differentiated thyroid cancer at intermediate or high risk of recurrence: a systematic review and a meta-analysis 135
Qualitative heterogeneous signal drop on chemical shift (Cs) mr imaging: Correlative quantitative analysis between cs signal intensity index and contrast washout parameters using t1-weighted sequences 131
Long-term prognostic value of the response to therapy assessed by laboratory and imaging findings in patients with differentiated thyroid cancer 129
Advances in functional imaging of differentiated thyroid cancer 129
Comparison of simultaneous 18F-2-[18F] FDG PET/MR and PET/CT in the follow-up of patients with differentiated thyroid cancer 126
Higher baseline TSH levels predict early hypothyroidism during cancer immunotherapy 125
Impairment of bone status in patients with central diabetes insipidus 125
La scintigrafia surrenalica con indio-111 octreotide in un caso di feocromocitoma maligno: confronto tra tecnica planare e tomografica (SPECT) 125
Insights into Myocardial Perfusion PET Imaging: the Coronary Flow Capacity 124
The Safety and Efficacy of Peptide Receptor Radionuclide Therapy for Gastro-Entero-Pancreatic Neuroendocrine Tumors: A Single Center Experience 124
Outcome of Patients With Differentiated Thyroid Cancer Treated With 131-Iodine on the Basis of a Detectable Serum Thyroglobulin Level After Initial Treatment 124
Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status 123
Combined therapy of Sr-89 and zoledronic acid in patients with painful bone metastases. 121
Intramedullary Spinal Cord Metastases from Differentiated Thyroid Cancer, a Case Report 121
Second Primary Malignancies in Patients with Differentiated Thyroid Cancer after Radionuclide Therapy: A Retrospective Single-Centre Study 120
Valutazione morfo-funzionale del rene nella fibrosi retroperitoneale: correlazioni tra tomografia computerizzata, risonanza magnetica e scintigrafia renale dinamica 118
The diagnostic role of total-body 18F-FDG PET/CT in patients with multiple tumors: a report of the association of thyroid cancer with lung or renal tumors 118
Initial Testing of an Approximated, Fast Calculation Procedure for Personalized Dosimetry in Radionuclide Therapy Based on Planar Whole-Body Scan and Monte-Carlo Specific Dose Rates from the OpenDose Project 118
Incremental value of sestamibi SPECT/CT over dual-phase planar scintigraphy in patients with primary hyperparathyroidism and inconclusive ultrasound 117
External validation of a predictive model for post-treatment persistent disease by 131I whole-body scintigraphy in patients with differentiated thyroid cancer 116
Efficacy of Empirical Radioiodine Therapy in Patients with Differentiated Thyroid Cancer and Elevated Serum Thyroglobulin without Evidence of Structural Disease: A Propensity Score Analysis 116
Postsurgical diagnostic evaluation of patients with differentiated thyroid carcinoma: comparison of ultrasound, iodine-131 scintigraphy and PET with fluorine-18 fluorodeoxyglucose. 116
Prognostic role of 18F-FDG PET/CT in the postoperative evaluation of differentiated thyroid cancer patients 116
Pancreatic Neuroendocrine Tumors in patients with Multiple Endocrine Neoplasia Type 1: Diagnostic Value of Different MRI Sequences 116
Risk of primary breast cancer in patients with differentiated thyroid cancer undergoing radioactive iodine therapy: a systematic review and meta-analysis 116
MR imaging characterization of pheochromocytoma: a comparison between typical and atypical tumor lesions 115
Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients. 115
Emerging Role of Nuclear Medicine in Prostate Cancer: Current State and Future Perspectives 114
Prognostic value of 12-month response to therapy in pediatric patients with differentiated thyroid cancer 113
Diagnostic Accuracy of Gd-EOB-DTPA for Detection Hepatocellular Carcinoma (HCC): A Comparative Study with Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) and Dynamic Contrast Enhanced Computed Tomography (CT) 113
Role of serial cardiac 18F-FDG PET-MRI in Anderson-Fabry disease: a pilot study 110
Combined bone scintigraphy and fluorocholine PET/computed tomography predicts response to radium-223 therapy in patients with prostate cancer 108
A case of an elderly patient with advanced disease and non-radioiodine-avid metastases 108
Effect of a short-term treatment with alendronate on bone density and bone markers in patients with central diabetes insipidus 107
Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients 107
Assessment of metabolic response to radioimmunotherapy with 90Y-ibritumomab tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphoma 107
Characterization of Atypical Pheochromocytomas with Correlative MRI and Planar/Hybrid Radionuclide Imaging: A Preliminary Study 105
Hyperfunctioning parathyroid gland and skeletal involvement on [18F]fluorocholine PET/CT: one look with two views 105
Characterization with hybrid imaging of cystic pheochromocytomas: Correlation with pathology 105
Subclinical hyperthyroidism: clinical features and treatment options. 104
Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study 102
“Ruolo della PET (tomografia ad emissione di positroni) con 2-(18F)Fluoro-2-Desossiglucosio (FDG) nel carcinoma differenziato della tiroide” 101
Cardiac hybrid imaging: novel tracers for novel targets 100
La tomografia a emissione di positroni (PET) con F-18 FDG nello studio delle formazioni espansive a sede surrenalica: confronto tra lesioni benigne e maligne 99
111In-pentetreotide scintigraphy in the post-thyroidectomy follow-up of patients with medullary thyroid carcinoma 97
Utilizzo del TSH ricombinante nella diagnostica del carcinoma differenziato della tiroide:trials multicentrici di validazione 97
Current Advances in Radioactive Iodine-Refractory Differentiated Thyroid Cancer 95
Preclinical imaging for the study of mouse models of thyroid cancer 95
The role of radiolabeled somatostatin analogs in adrenal imaging. 94
Cardovascular safety of acute recombinant human thyrotropin administration in patients monitored for differentiated thyroid cancer. 93
Expanding the long‑axial feld‑of‑view PET‑CT horizons: unveiling new arrows in our quiver 92
Diagnostica integrata del feocromocitoma 92
Metastatic castration‑resistant prostate cancer therapy: the quest for the perfect molecule 91
131I-meta-iodobenzylguanidine scintigraphy in patients with a suspected pheochromocytoma. A comparison with CT and biohumoral parameters 91
Role of the neck ultrasonography, of thyroglobulin after rhTSH and of FDGPET in post surgical follow-up of differentiated thyroid cancer 90
Parathyroid scintigraphy with 99mTc-MIBI in hyperparathyroidism. A comparison between diagnostic imaging technics in the location and characterization of glandular hyperfunction and in the evaluation of skeletal changes 88
L'incidenza della scoliosi in rapporto a disturbi endocrini nell'età evolutiva 88
New opportunities for dosimetric approach in patients with differentiated thyroid cancer 88
Non-Hodgkin's lymphoma in a patient with follicular thyroid cancer: the role of Tc-99m methoxy isobutyl isonitrile imaging 87
PET/CT in the management of differentiated thyroid cancer 86
Tetrofosmin thyroid scintigraphy 85
Tc-99m MIBI imaging in the initial diagnosis and post-surgery follow-up of patients with thyroid cancer 85
Cardiovascular safety of acute recombinant human thyrotropin administration to patients monitored for differentiated thyroid cancer. 85
Total thyroidectomy, without prophylactic central lymph node dissection, in the treatment of differentiated thyroid cancer. Clinical retrospective study on 221 cases. 85
The role of radiolabeled somatostatin analogs in adrenal imaging. 84
Comparison of labeled MIBG and somatostatin analogs in imaging neuroendocrine tumors 84
Diagnostic evaluation of thyroid involvement by histiocytosis X. 82
Familial pheochromocytoma in Sipple's syndrome. A comparison between scintigraphy with 131I-meta-iodobenzylguanidine, computed tomography and echography 81
Radionuclide imaging of neuroendocrine tumors: a comparative study using radiolabeled MIBG and octreotide. 81
The use of recombinant human TSH in the follow-up of differentiated thyroid thyroid cancer: experience from a large pateint cohort in a single centre. 80
Diagnostic accuracy of radionuclide imaging using 131I nor-cholesterol or meta-iodobenzylguanidine in patients with hypersecreting or non-hypersecreting adrenal tumours. 80
Prognostic role of FDG PET/CT in patients with differentiated thyroid cancer treated with 131-iodine empiric therapy 77
Diagnostic accuracy of radionuclide imaging using iodine-131 nor-cholesterol or MIBG in patients with hypersecreting or non-hypersecreting adrenal tumors. 76
Valutazione diagnostica post-chirurgica di pazienti con carcinoma tiroideo differenziato: confronto tra ecografia, scintigrafia con iodio-131 e PET con fluoro-18 fluorodesossiglucosio. 76
Growth hormone deficiency in elderly patients with hypothalamo-pituitary tumors 75
Short-term outcome of differentiated thyroid cancer patients receiving a second iodine-131 therapy on the basis of a detectable serum thyroglobulin level after initial treatment. 75
[Adrenal scintigraphy with Indium-111 octreotide in a case of malignant pheochromocytoma: comparison of the planar and tomographic technique (SPECT)]. 75
Funzione ventricolare sinistra in pazienti con deficit dell'ormone della crescita. Valutazione con angiografia radionuclidica 75
Decreased serum vascular endothelial growth factor-D levels in metastatic patients with differentiated thyroid carcinoma. 73
Totale 11.139
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.627
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.627
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202132 0 0 0 0 0 0 0 0 0 0 0 32
2021/2022837 31 13 33 27 25 15 9 35 108 34 161 346
2022/2023728 141 37 24 30 92 74 7 69 87 107 41 19
2023/2024758 40 89 76 74 52 83 29 66 17 18 136 78
2024/20253.952 210 268 10 12 103 242 448 242 310 425 1.371 311
2025/20267.313 860 575 811 708 1.262 257 779 468 865 513 176 39
Totale 14.935